Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamie R Rich

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Molecular Cancer Therapeutics|February 14, 2024
Design and Evaluation of ZD06519, a Novel Camptothecin Payload for Antibody Drug ConjugatesMark E Petersen, Michael G Brant, Manuel Lasalle, et al.
European Urology|April 15, 2017
An Oncofetal Glycosaminoglycan Modification Provides Therapeutic Access to Cisplatin-resistant Bladder CancerRoland Seiler, Htoo Zarni Oo, Davide Tortora, et al.
Cancer Cell|October 14, 2015
Targeting Human Cancer by a Glycosaminoglycan Binding Malaria ProteinAli Salanti, Thomas M Clausen, Mette Ø Agerbæk, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Molecular Cancer Therapeutics|February 14, 2024
Design and Evaluation of ZD06519, a Novel Camptothecin Payload for Antibody Drug ConjugatesMark E Petersen, Michael G Brant, Manuel Lasalle, et al.
European Urology|April 15, 2017
An Oncofetal Glycosaminoglycan Modification Provides Therapeutic Access to Cisplatin-resistant Bladder CancerRoland Seiler, Htoo Zarni Oo, Davide Tortora, et al.
Cancer Cell|October 14, 2015
Targeting Human Cancer by a Glycosaminoglycan Binding Malaria ProteinAli Salanti, Thomas M Clausen, Mette Ø Agerbæk, et al.
Pageof 3